Sandu Pharmaceuticals Faces Market Struggles Amid Significant Decline Over Past Year

Sandu Pharmaceuticals has been experiencing significant challenges in the market, recently closing at Rs 52.6, which marks a 52-week low. The stock is currently just 0.23% above this low point, indicating a precarious position. In today's trading session, Sandu Pharmaceuticals underperformed its sector with a decline of 0.38%, contributing to a total decrease of 2.35% over the past two days. The company's performance metrics reveal a consistent downward trend, as it is trading below its moving averages across multiple time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Over the past year, Sandu Pharmaceuticals has seen a decline of 25.21%, a stark contrast to the Sensex's gain of 5.35%. This disparity underscores the difficulties Sandu Pharmaceuticals is facing in the current market landscape.